Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA
Phase 1
- Conditions
- Diabetic Peripheral Neuropathic Pain
- Interventions
- Drug: PlaceboDrug: CBD/PEA
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- Pure Green Pharmaceuticals Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT05766969
- Locations
- 🇺🇸
Pure Green Pharmaceuticals Inc., Southfield, Michigan, United States
News
No news found